Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
Immix Biopharma Inc (NASDAQ: IMMX) closed the day trading at $5.94 down -4.27% from the previous closing price of $6.2. In other words, the price has decreased by -$4.27 from its previous closing price. On the day, 1.19 million shares were traded. IMMX stock price reached its highest trading level at $6.4799 during the session, while it also had its lowest trading level at $5.796.
Ratios:
For a better understanding of IMMX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.53 and its Current Ratio is at 1.53. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.12.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 10 ’25 when Rachman Ilya M bought 746 shares for $6.67 per share. The transaction valued at 4,976 led to the insider holds 1,141,683 shares of the business.
Morris Gabriel S bought 770 shares of IMMX for $5,067 on Dec 10 ’25. The CFO now owns 291,429 shares after completing the transaction at $6.58 per share. On Sep 17 ’25, another insider, Rachman Ilya M, who serves as the CEO and Chairman of the company, bought 2,500 shares for $2.02 each. As a result, the insider paid 5,050 and bolstered with 1,140,937 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMMX now has a Market Capitalization of 313011392 and an Enterprise Value of 184611600.
Stock Price History:
The Beta on a monthly basis for IMMX is 0.27, which has changed by 1.954762 over the last 52 weeks, in comparison to a change of 0.16081822 over the same period for the S&P500. Over the past 52 weeks, IMMX has reached a high of $7.73, while it has fallen to a 52-week low of $1.34. The 50-Day Moving Average of the stock is 49.22%, while the 200-Day Moving Average is calculated to be 128.35%.
Shares Statistics:
Over the past 3-months, IMMX traded about 830.82K shares per day on average, while over the past 10 days, IMMX traded about 2096250 shares per day. A total of 52.70M shares are outstanding, with a floating share count of 33.53M. Insiders hold about 36.37% of the company’s shares, while institutions hold 5.49% stake in the company. Shares short for IMMX as of 1764288000 were 1369590 with a Short Ratio of 1.65, compared to 1761868800 on 848278. Therefore, it implies a Short% of Shares Outstanding of 1369590 and a Short% of Float of 6.17.
Earnings Estimates
The stock of Immix Biopharma Inc (IMMX) is currently in the spotlight, with 1.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.14 and low estimates of -$0.14.
Analysts are recommending an EPS of between -$0.68 and -$0.77 for the fiscal current year, implying an average EPS of -$0.73. EPS for the following year is -$0.64, with 2.0 analysts recommending between -$0.64 and -$0.65.
